Biotech Stockholders Challenge Director Pay Levels In Del.
By Jeff Montgomery · May 20, 2025, 6:32 PM EDT
Investors in biotech company Intellia Therapeutics Inc. stock opened a derivative suit in Delaware's Court of Chancery on Tuesday seeking recovery of allegedly excessive compensation paid to non-employee directors for multiple...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login